- Home
- QH vs KTTA Comparison
QH vs KTTA Comparison
Compare QH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QH
- KTTA
- Stock Information
- Founded
- QH 2012
- KTTA 2020
- Country
- QH China
- KTTA United States
- Employees
- QH N/A
- KTTA N/A
- Industry
- QH Business Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- QH Consumer Discretionary
- KTTA Health Care
- Exchange
- QH Nasdaq
- KTTA Nasdaq
- Market Cap
- QH 6.6M
- KTTA 5.5M
- IPO Year
- QH 2020
- KTTA 2021
- Fundamental
- Price
- QH $7.05
- KTTA $0.81
- Analyst Decision
- QH
- KTTA
- Analyst Count
- QH 0
- KTTA 0
- Target Price
- QH N/A
- KTTA N/A
- AVG Volume (30 Days)
- QH 129.9K
- KTTA 93.8K
- Earning Date
- QH 09-26-2025
- KTTA 11-12-2025
- Dividend Yield
- QH N/A
- KTTA N/A
- EPS Growth
- QH N/A
- KTTA N/A
- EPS
- QH 0.33
- KTTA N/A
- Revenue
- QH $357,118,848.00
- KTTA N/A
- Revenue This Year
- QH N/A
- KTTA N/A
- Revenue Next Year
- QH N/A
- KTTA N/A
- P/E Ratio
- QH $25.84
- KTTA N/A
- Revenue Growth
- QH N/A
- KTTA N/A
- 52 Week Low
- QH $3.93
- KTTA $0.65
- 52 Week High
- QH $169.07
- KTTA $5.45
- Technical
- Relative Strength Index (RSI)
- QH 59.16
- KTTA 61.44
- Support Level
- QH $5.95
- KTTA $0.70
- Resistance Level
- QH $10.85
- KTTA $0.84
- Average True Range (ATR)
- QH 0.96
- KTTA 0.03
- MACD
- QH 0.02
- KTTA 0.01
- Stochastic Oscillator
- QH 28.71
- KTTA 81.57
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).